Psychiatric services for elderly people are based on principles which are relevant to
It may seem that psychiatry has little to offer neurology in the management of chronic neurological disability. However, psychiatrists have a long association with neurological disability, often assuming responsibility for certain groups of patients and being involved in the treatment of the psychiatric sequelae in others. The psychiatric morbidity may be associated with the difficulties in adjusting to the illness, as a result of altered behaviour due to brain damage, or as a result of treatment of the underlying condition.
In recent years psychogeriatricians have taken on the mantle of organic psychiatry and have developed wide experience in the management of dementia. They are involved in the whole range of psychiatric illness and place great emphasis on the curative aspect of the work, particularly the diagnosis and treatment of depression.
There are few chronic irreversible diseases which do not precipitate depression in some of their sufferers and acknowledgement of that, and sensitivity to the patients' feelings are an important part of the response to therapy. If clinicians want to be truly involved in the management of chronic disability they will have to heed the patients' experience of their illness. There can be little benefit in telling the patient he is technically better if he does not feel better.
Such assertions undermine the patients' confidence in the doctor who is then seen to be unhelpful with no understanding of their "real" problems. The patient may then be reluctant to express his or her feelings and problems for fear that they will be dismissed, and compliance with treatment may then suffer. In Parkinson's disease, for example, the loss of tremor and decreased tone are important therapeutic goals, but if they are achieved at the expense of disturbed nights which increase carer strain with consequent irritability, the patient may not benefit. A patient may be seen as difficult when he refuses a catheter for urinary incontinence despite the obvious burden to his wife, but it may be that no one has asked about his sexual activity and addressed his fears of how catheterisation may take away his last vestige of self-esteem.
Lists and outweighs the lack of specialist equipment. They have been able to care for profoundly demented patients and have also been able to provide imaginative integration of chronically functionally ill patients using individual and group therapies.
We are, however, facing an increasing burden particularly from the organic disorders; we see around 400 cases of dementia each year, as well as those that are functionally ill. That means we see about eight cases of dementia that are totally new to our service each week. Clearly the vast majority of these patients are not, and cannot be, extensively investigated. Virtually none will have CT brain scans, because until recently our service had been denied access unless the scan was authorised by a neurologist.
It has now become easier to arrange scans, but if we had carte blanche we would certainly not scan them all, as I do not share with others the touching faith in CT scanning and its ability to aid diagnosis in clinically demented patients. Although it may be heresy to say so, the management of these patients is unlikely to be influenced by the result, whether it shows multi-infarct or frontal dementia, gross atrophy or a normal scan. Even signs of normal pressure hydrocephalus seem to result in very little surgical intervention these days. Dementia is a clinical diagnosis and no amount of investigation will alter this fact. The precise cause will matter very little in the day to day management of the patient unless a significant treatment for any of the dementing processes emerges. What is far more important is ensuring the carer has access to, and help with all the relief, aids and allowances they can obtain. Also that the carer has a hot line that brings an immediate response and, when the chips are down, same day admission for respite. It is important that the community psychiatric nurse, day hospital, occupational therapy assessment, day centre, sitting service, carers groups, home care and any other relevant support are introduced with speed and sensitivity.
That is the way to reduce disability. By following the patient one can be aware of change in the patient. If the carer starts calling for help when the patient appears no worse, one can be aware of carer strain and probable depression which needs urgent treatment or support rather than being brushed off with comments that there appears to be no deterioration in the patient or by tinkering with his medication-as one might do if seeing the patient in isolation in a clinic.
It would be helpful if greater liaison and awareness of neurological and psychogeriatric services were possible. At the moment things are rather haphazard, in that either service might become involved depending on which door the patient knocks on first. What I would like is that whichever door it is, the patient is able to enjoy the benefit of either service. What I do not want is to get referrals of patients with dementia from general practitioners who say "Mrs A has been stoically coping with her husband who was investigated at the neurological centre two years ago and diagnosed as having Alzheimer's disease. She is now finding it difficult to cope, could you assess?" She should have been having support two years ago and might not be collapsing now if she had. I never object to seeing people early in their dementia. I am distressed by picking up the pieces of an already shattered caring network which no amount of psychogeratric superglue can fix.
Although I have been mainly addressing dementia, Parkinson's disease is probably the illness which epitomises the need for liaison. I find the management of patients with Parkinson's disease who are referred to me very difficult for a variety of reasons, but particularly because of the complex nature of the interaction between functional disturbances and organic illness.
In two summer months we saw 34 patients with Parkinsonian symptoms including 11 new cases and 23 follow up visits and there were six admissions to the psychiogeriatric unit. If we extrapolate we might see about 60 new cases of PD or Parkinsonism in a year who generate perhaps some 300 visits, including follow ups.
Men and women were equally represented, but although the average age of the women was slightly higher it was interesting that less than 20% of the men were over 80, whereas half of the women were. It is my impression that men with Parkinson's disease cause much more work in terms of behavioural and psychological problems, and whether they have a greater mortality as a result, or whether the figures simply reflect the expected demography, is uncertain.
If we look at the cause of these symptoms about 65% had idiopathic Parkinson's disease (14 male and 8 female). There were more women (10) in the iatrogenic group than men (2), which agrees with Ayd's work suggesting drug induced Parkinson's disease is correlated with older age and female gender."3
The 12 patients with drug induced symptoms could be divided into three groups. Five were chronic schizophrenics on long term neuroleptic drugs, one of whom also had buccolingual dsykinesia. Three had dementia with symptoms attributable to long term neuroleptics given for behavioural or psychotic symptoms-these patients are not routinely given anticholinergenics. Four had depression and all four were on flupenthixol 0 5 mg daily as well a tricyclic antidepressent and three were also on lithium. There may be a synergism between flupenthixol and lithium in inducing extrapyramidal signs, as has been noted with higher doses of haloperidol and some depot neuroleptics and lithium.
Half of the new cases were referred because of the visual hallucinations often regarded as secondary to medication for their Parkinson's disease. Perry'4 suggests that Lewy body type dementia is associated with visual hallucinations and that some patients with Parkinson's disease may have hallucinations as a result of this rather than as a complication of their treatment. This agrees with my experience.
Half of the patients were referred because of depression, 35% because of dementia, and 15% because of schizophrenia.
As I have already described, our management of these patients is often supportive. Those on neuroleptic drugs need constant review to keep the balance of medication effective and many are a constant reminder of how fallible and impotent we are as specialists in the relief of certain forms of intractable distress. What is clear is that we need a more eclectic view of this and many other diseases.
In old age psychiatry, the advent of new imaging techniques seems to show that depres-sion"" is associated with changes in structure and function of the brain as does schizophrenia.'8 As ever in psychiatry we seem to have completed another circle. The seminal work of Sir Martin Roth in the 1950s"9 identified depression and dementia as distinct entities among what had hitherto been encompassed by the term senile psychosis. This distinction seems less obvious and secure now. Consequently, we have to work together, and learn from each other. Accurate lesion finding and diagnosis may be of crucial importance for psychogeriatrics if new treatments are found for any of the disease processes so far crudely incorporated under the Alzheimer's disease label. This will be especially true if these treatments have significant side effects. Neurologists may wish to spend more time considering the after-care and rehabilitation role with patients, an area as rewarding as the quest for the lesion.
